rs61746966
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001101426.4(CRPPA):c.726A>G(p.Gln242Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00505 in 1,611,086 control chromosomes in the GnomAD database, including 305 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001101426.4 synonymous
Scores
Clinical Significance
Conservation
Publications
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- myopathy caused by variation in CRPPAInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive limb-girdle muscular dystrophy type 2UInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- congenital muscular dystrophy without intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRPPA | NM_001101426.4 | c.726A>G | p.Gln242Gln | synonymous_variant | Exon 4 of 10 | ENST00000407010.7 | NP_001094896.1 | |
CRPPA | NM_001101417.4 | c.576A>G | p.Gln192Gln | synonymous_variant | Exon 3 of 9 | NP_001094887.1 | ||
CRPPA | NM_001368197.1 | c.685-7120A>G | intron_variant | Intron 3 of 8 | NP_001355126.1 | |||
CRPPA | NR_160656.1 | n.901-30360A>G | intron_variant | Intron 3 of 7 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0270 AC: 4107AN: 152124Hom.: 165 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00704 AC: 1729AN: 245698 AF XY: 0.00529 show subpopulations
GnomAD4 exome AF: 0.00274 AC: 3996AN: 1458844Hom.: 137 Cov.: 29 AF XY: 0.00231 AC XY: 1679AN XY: 725450 show subpopulations
GnomAD4 genome AF: 0.0271 AC: 4133AN: 152242Hom.: 168 Cov.: 33 AF XY: 0.0268 AC XY: 1993AN XY: 74432 show subpopulations
ClinVar
Submissions by phenotype
not specified Benign:5
- -
- -
Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7;C5190987:Autosomal recessive limb-girdle muscular dystrophy type 2U Benign:1
- -
Congenital Muscular Dystrophy, alpha-dystroglycan related Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at